Norges Bank Castle Biosciences Inc Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$13.28 - $20.3 $1.81 Million - $2.77 Million	-136,600 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$19.47 - $28.49 $1.2 Million - $1.75 Million	61,600 New	61,600 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $2.37 Million - $3.94 Million	131,200 New	131,200 $3.09 Million
Q3 2022 Nov 13, 2023	BUY	$22.51 - $34.32 $3.07 Million - $4.69 Million	136,600 New	136,600 $3.56 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.